Dental

The global dental sector is easily among the healthcare areas with the best prospects as dental care is becoming increasingly accessible and affordable in countries all over the world. The global market for dental supplies is expected to reach a value of US$19.4 billion by the year 2017. The key growth drivers are: aging population, increasing awareness about oral care, rise in demand for preventive and cosmetic dental procedures, and technological developments.

Do you want to be a leading player in this growing market? Make informed business decisions with the reliable data and forecasts provided by the publications listed under Research and Markets’ Dental category. You will have at your disposal a wealth of information on the latest technologies, market trends, forecasts, key players and new business opportunities in the dental industry.

The reports, books, and subscriptions of this category cover both dental consumables and dental equipment. Dental consumables include crowns and bridges, implants, pharmaceuticals, orthodontics, impressive materials, composites, endodontics, adhesives and cement. Dental equipments include autoclaves, sterilizers, chairs, communication systems, compressors, cuspidors and digital imaging system and small equipment such as amalgam removal systems, amalgamators, handpiece cleaners, lab equipment, duplicators and ultrasonic cleaners. Show Less ... more

• Nanobiomaterials in Clinical Dentistry

  EURO€ 121.00USD$ 157.00GBP£ 102.00AUD$ 154.00JPY¥ 15,542.00SEK 1 034,00CHF 148.00CAD$ 160.00 Elsevier Science and Technology, Dec 2012 , Pages: 544
  New nanomaterials are leading to a range of emerging dental treatments that utilize more biomimetic materials that more closely duplicate natural tooth structure (or bone, in the case of implants). This...

• 2013 U.S. Offices of Dentists Industry-Capital & Expenses Report

  EURO€ 115.00USD$ 149.00GBP£ 96.00AUD$ 146.00JPY¥ 14,711.00SEK 978,00CHF 140.00CAD$ 152.00 Barnes Reports, Dec 2012 , Pages: 221
  The 2013 U.S. Offices of Dentists Industry-Capital & Expenses Report, published annually , contains timely and accurage industry statistics, forecasts and demographics. The report features 2013 current...

• 2013 Trendology: U.S. Offices of Dentists

  EURO€ 230.00USD$ 299.00GBP£ 193.00AUD$ 292.00JPY¥ 29,521.00SEK 1 963,00CHF 282.00CAD$ 305.00 Trendology Research, Dec 2012 , Pages: 125
  The 2013 Trendology report on the U S Offices of Dentists industry characterizes the industry in three descriptive methods: qualitative analysis, quantitative data and lists of major industry players...

• 2013 Worldwide Offices of Dentists Industry-Industry & Market Report

  EURO€ 191.00USD$ 249.00GBP£ 161.00AUD$ 244.00JPY¥ 24,585.00SEK 1 635,00CHF 235.00CAD$ 254.00 Barnes Reports, Dec 2012 , Pages: 104
  The 2013 Worldwide Offices of Dentists Industry-Industry & Market Report, published annually , contains timely and accurate industry statistics, forecasts and demographics The report features 2013 current...

• Dental Equipment Manufacturing in China

  EURO€ 699.00USD$ 910.00GBP£ 588.00AUD$ 890.00JPY¥ 89,847.00SEK 5 975,00CHF 858.00CAD$ 927.00 IBISWorld, Dec 2012 , Pages: 34
  Dental Equipment Manufacturing in China The Dental Equipment Manufacturing industry in China produces dental treatment units, dental chairs, and other dental equipment and supplies. This report covers...

• Soft-Tissue Lasers in Dental Hygiene

  EURO€ 53.00USD$ 70.00GBP£ 45.00AUD$ 68.00JPY¥ 6,869.00SEK 457,00CHF 66.00CAD$ 71.00 John Wiley and Sons Ltd, Dec 2012 , Pages: 240
  The uses and benefits of soft-tissue lasers in dental hygiene practice are myriad. Lasers are used for more effective debridement, scaling and planning, with less pain and bleeding. Hygienists can detect...

• Consumer and Innovation Trends in Oral Hygiene

  EURO€ 2,652.00USD$ 3,450.00GBP£ 2,231.00AUD$ 3,374.00JPY¥ 340,629.00SEK 22 652,00CHF 3'252.00CAD$ 3,515.00 Datamonitor, Dec 2012 , Pages: 98
  As consumer trends drive innovation and purchasing behavior, it is increasingly vital to understand how to shape products to best meet these. This brief outlines the most important consumer and product...

• Arcadia Resources Inc.,(KADR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arcadia Resources Inc. (KADR), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtCor Medical Holdings Limited,(AMDHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtCor Medical Holdings Limited (AMDHF), plus vital industry benchmarks and extensive operating ratios, along...

• Baxter International Inc,(BAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Baxter International Inc (BAX), plus vital industry benchmarks and extensive operating ratios, along with...

• Atrion Corporation,(ATRI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Atrion Corporation (ATRI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Avitar, Inc.,(AVTI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Avitar, Inc. (AVTI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• ArQule Inc,(ARQL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArQule Inc (ARQL), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• ArthroCare Corp,(ARTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArthroCare Corp (ARTC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Assurant Inc,(AIZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assurant Inc (AIZ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AstraZeneca plc,(AZN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AstraZeneca plc (AZN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Athenahealth Inc,(ATHN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Athenahealth Inc (ATHN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Banyan Corporation,(BNYN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Banyan Corporation (BNYN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Astellas Pharma Inc,(ALPMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Astellas Pharma Inc (ALPMY), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtriCure, Inc.,(ATRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtriCure, Inc. (ATRC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AxoGen Inc,(AXGN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AxoGen Inc (AXGN), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Arrhythmia Research Technology,(HRT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arrhythmia Research Technology (HRT), plus vital industry benchmarks and extensive operating ratios, along...

• Assisted Living Concepts Inc.,(ALC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assisted Living Concepts Inc. (ALC), plus vital industry benchmarks and extensive operating ratios, along...

• Integra Lifesciences Holdings Corp,(IART) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Integra Lifesciences Holdings Corp (IART), plus vital industry benchmarks and extensive operating ratios,...

• Intraop Medical Corporation,(IOPD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Intraop Medical Corporation (IOPD), plus vital industry benchmarks and extensive operating ratios, along with...

• Kewaunee Scientific Corp.,(KEQU) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kewaunee Scientific Corp. (KEQU), plus vital industry benchmarks and extensive operating ratios, along with...

• Integrated Healthcare Holdings, Inc.,(IHCH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Integrated Healthcare Holdings, Inc. (IHCH), plus vital industry benchmarks and extensive operating ratios,...

• IntriCon Corporation,(IIN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for IntriCon Corporation (IIN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Kensey Nash Corporation,(KNSY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kensey Nash Corporation (KNSY), plus vital industry benchmarks and extensive operating ratios, along with...

• Kimberly-Clark Corp,(KCDMF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kimberly-Clark Corp (KCDMF), plus vital industry benchmarks and extensive operating ratios, along with an...

• Kinetic Concepts Inc (KCI),(KCIAL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kinetic Concepts Inc (KCI) (KCIAL), plus vital industry benchmarks and extensive operating ratios, along with...

• Electromed Inc,(ELMD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Electromed Inc (ELMD), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Eli Lilly & Company,(LLY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Eli Lilly & Company (LLY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Five Star Quality Care, Inc.,(FVE) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Five Star Quality Care, Inc. (FVE), plus vital industry benchmarks and extensive operating ratios, along with...

• Fonar Corporation,(FONR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Fonar Corporation (FONR), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• GlaxoSmithKline plc,(GSK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for GlaxoSmithKline plc (GSK), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Golden Meditech,(GMDTF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Golden Meditech (GMDTF), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Catasys Inc,(CATS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Catasys Inc (CATS), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Centene Corporation,(CNC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Centene Corporation (CNC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Commonwealth Biotechnologies, Inc.,(CBTEQ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Commonwealth Biotechnologies, Inc. (CBTEQ), plus vital industry benchmarks and extensive operating ratios,...

• iSonea Ltd,(ISOAY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for iSonea Ltd (ISOAY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• IsoRay, Inc.,(ISR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for IsoRay, Inc. (ISR), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• DrugMax Inc,(FMRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for DrugMax Inc (FMRX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Computer Vision Systems Laboratories Corp.,(CVSL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Computer Vision Systems Laboratories Corp. (CVSL), plus vital industry benchmarks and extensive operating...

• Cross Atlantic Commodities, Inc.,(CXAC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Cross Atlantic Commodities, Inc. (CXAC), plus vital industry benchmarks and extensive operating ratios, along...

• CSL Limited,(CMXHY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for CSL Limited (CMXHY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Diagnostic Imaging International Corporation,(DIIG) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Diagnostic Imaging International Corporation (DIIG), plus vital industry benchmarks and extensive operating...

• Institut Straumann AG,(SAUHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Institut Straumann AG (SAUHF), plus vital industry benchmarks and extensive operating ratios, along with an...

• Laboratory Corp of America Holdings,(LH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Laboratory Corp of America Holdings (LH), plus vital industry benchmarks and extensive operating ratios, along...

• 3SBio Inc,(SSRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for 3SBio Inc (SSRX), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...